Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome.

Georgiou P, Maroulakou I, Green J, Dantis P, Romanospica V, Kottaridis S, Lautenberger J, Watson D, Papas T, Fischinger P, Bhat N.

Int J Oncol. 1996 Jul;9(1):9-18.

PMID:
21541474
2.

Pleiotropic functions of ETS-1 (Review).

Bhat N, Fischinger P, Seth A, Watson D, Papas T.

Int J Oncol. 1996 May;8(5):841-6.

PMID:
21544435
3.

Similarities between somatic cells overexpressing the mos oncogene and oocytes during meiotic interphase.

Fukasawa K, Murakami MS, Blair DG, Kuriyama R, Hunt T, Fischinger P, Vande Woude GF.

Cell Growth Differ. 1994 Oct;5(10):1093-103.

4.

The evolving perspective of prostate cancer: a question of natural history and current treatment trends.

Fischinger PJ.

J S C Med Assoc. 1994 May;90(5):242-8. Review. No abstract available.

PMID:
8028297
5.

Prospects for reducing virus-associated human cancers by antiviral vaccines.

Fischinger PJ.

J Natl Cancer Inst Monogr. 1992;(12):109-14. Review.

PMID:
1616793
6.

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.

Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, Goudsmit J.

J Virol. 1990 Aug;64(8):3779-91.

7.

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

Pyle SW, Morein B, Bess JW Jr, Akerblom L, Nara PL, Nigida SM Jr, Lerche NW, Robey WG, Fischinger PJ, Arthur LO.

Vaccine. 1989 Oct;7(5):465-73.

PMID:
2554608
8.

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.

Nara PL, Robey WG, Pyle SW, Hatch WC, Dunlop NM, Bess JW Jr, Kelliher JC, Arthur LO, Fischinger PJ.

J Virol. 1988 Aug;62(8):2622-8.

9.
10.

Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.

Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ.

J Gen Virol. 1988 Jul;69 ( Pt 7):1711-7.

PMID:
2839603
11.

The development of an AIDS vaccine: progress and promise.

Fauci AS, Fischinger PJ.

Public Health Rep. 1988 May-Jun;103(3):230-6.

12.

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, et al.

Proc Natl Acad Sci U S A. 1988 May;85(9):3198-202. Erratum in: Proc Natl Acad Sci U S A 1988 Nov;85(22):8697. Proc Natl Acad Sci U S A 1989 Mar;86(5):1667.

13.

Quantitative infectivity assay for HIV-1 and-2.

Nara PL, Fischinger PJ.

Nature. 1988 Mar 31;332(6163):469-70. No abstract available.

PMID:
3281026
14.

Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.

Zweig M, Showalter SD, Bladen SV, Gilden RV, Arthur LO, Robey WG, Nara PL, Fischinger PJ.

AIDS Res Hum Retroviruses. 1988 Feb;4(1):51-62. Erratum in: AIDS Res Hum Retroviruses 1988 Jun;4(3):237.

PMID:
3259140
15.

Microinjection and expression of an infectious proviral clone and subgenomic envelope construct of a human immunodeficiency virus.

Boyd AL, Wood TG, Buckley A, Fischinger PJ, Gilden RV, Gonda MA.

AIDS Res Hum Retroviruses. 1988 Feb;4(1):31-41.

PMID:
2835071
16.

Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.

Nara PL, Robey WG, Arthur LO, Asher DM, Wolff AV, Gibbs CJ Jr, Gajdusek DC, Fischinger PJ.

J Virol. 1987 Oct;61(10):3173-80.

17.
18.
20.

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.

Cease KB, Margalit H, Cornette JL, Putney SD, Robey WG, Ouyang C, Streicher HZ, Fischinger PJ, Gallo RC, DeLisi C, et al.

Proc Natl Acad Sci U S A. 1987 Jun;84(12):4249-53. Erratum in: Proc Natl Acad Sci U S A 1988 Nov;85(21):8226.

21.

Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.

Henderson LE, Sowder R, Copeland TD, Oroszlan S, Arthur LO, Robey WG, Fischinger PJ.

J Virol. 1987 Feb;61(2):629-32.

22.
23.

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.

Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ.

AIDS Res Hum Retroviruses. 1987 Fall;3(3):283-302.

PMID:
3481271
24.

Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins.

Robey WG, Nara PL, Poore CM, Popovic M, McLane MF, Barin F, Essex M, Fischinger PJ.

AIDS Res Hum Retroviruses. 1987;3(4):401-8.

PMID:
2833916
25.

Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells.

Pyle SW, Bess JW Jr, Robey WG, Fischinger PJ, Gilden RV, Arthur LO.

AIDS Res Hum Retroviruses. 1987;3(4):387-400.

PMID:
2833915
26.

Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.

Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP.

Haematol Blood Transfus. 1987;31:414-22.

PMID:
2832276
27.

Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation.

Nara PL, Robey WG, Arthur LO, Gonda MA, Asher DM, Yanagihara R, Gibbs CJ Jr, Gajdusek DC, Fischinger PJ.

Arch Virol. 1987;92(1-2):183-6.

PMID:
2432853
28.

Toward a vaccine against AIDS: rationale and current progress.

Fischinger PJ, Gallo RC, Bolognesi DP.

Mt Sinai J Med. 1986 Dec;53(8):639-47. No abstract available.

PMID:
3027544
29.

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP.

Proc Natl Acad Sci U S A. 1986 Dec;83(24):9709-13.

30.

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.

Robey WG, Arthur LO, Matthews TJ, Langlois A, Copeland TD, Lerche NW, Oroszlan S, Bolognesi DP, Gilden RV, Fischinger PJ.

Proc Natl Acad Sci U S A. 1986 Sep;83(18):7023-7.

31.

Properties of mouse leukemia viruses: XX. Variation of AKR Substrains in response to antibody therapy.

Schwarz H, Thiel HJ, Weinhold K, Fischinger P, Bolognesi D, Schäfer W.

Virology. 1986 Apr 15;150(1):247-51.

PMID:
3952985
32.

HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus.

Gilden RV, Arthur LO, Robey WG, Kelliher JC, Graham CE, Fischinger PJ.

Lancet. 1986 Mar 22;1(8482):678-9. No abstract available.

PMID:
2869366
33.

Prospects for treatment of human retrovirus-associated diseases.

Bolognesi DP, Fischinger PJ.

Cancer Res. 1985 Sep;45(9 Suppl):4700s-4705s. Review.

34.

Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).

Fischinger PJ, Robey WG, Koprowski H, Gallo RC, Bolognesi DP.

Cancer Res. 1985 Sep;45(9 Suppl):4694s-4699s. Review.

35.

Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.

Robey WG, Safai B, Oroszlan S, Arthur LO, Gonda MA, Gallo RC, Fischinger PJ.

Science. 1985 May 3;228(4699):593-5.

PMID:
2984774
36.

Generation of thymotropic envelope gene recombinant virus and induction of lymphoma by ecotropic Moloney murine leukemia virus.

Fischinger PJ, Dunlop NM, Robey WG, Schäfer W.

Virology. 1985 Apr 15;142(1):197-205.

PMID:
4060571
37.

Thymotropic envelope gene recombinants of Moloney leukemia virus have highly conserved envelope structures.

Robey WG, Dekaban GA, Ball JK, Poore CM, Fischinger PJ.

Virology. 1985 Apr 15;142(1):183-96.

PMID:
2997979
38.

Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus.

Fischinger PJ, Dunlop NM, Robey WG.

Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):241-51.

PMID:
2982768
39.

Acquired immune deficiency syndrome: the causative agent and the evolving perspective.

Fischinger PJ.

Curr Probl Cancer. 1985 Jan;9(1):1-39. Review. No abstract available.

PMID:
2983936
40.
41.

Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus.

Weinhold KJ, Hüper G, Matthews TJ, Fischinger PJ, Ihle JN, Schwarz H, Thiel HJ, Schäfer W, Bolognesi DP.

Virology. 1984 May;135(1):105-17.

PMID:
6328742
42.

The role of viral and cellular recombinational events in murine leukemia.

Fischinger PJ, Dunlop NM, Dekaban GA, Robey WG.

Transplant Proc. 1984 Apr;16(2):428-34. No abstract available.

PMID:
6326352
43.

Advanced computing.

Fischinger PJ.

Science. 1984 Mar 30;223(4643):1350. No abstract available.

PMID:
17746037
44.

Generation of recombinant murine leukemia viruses de novo: an alternative model for leukemogenesis.

Fischinger PJ, Dunlop NM, Poore CM, Robey WG.

Haematol Blood Transfus. 1983;28:261-9.

PMID:
6305796
45.

Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells.

Fischinger PJ, Thiel HJ, Lieberman M, Kaplan HS, Dunlop NM, Robey WG.

Cancer Res. 1982 Nov;42(11):4650-7. No abstract available.

46.

Persistence of one species of oncovirus in mixed infection after antiserum treatment or transspecies rescue.

Fischinger PJ, Robey WG, Blair DG, Blevins CS, Dunlop NM.

J Gen Virol. 1982 Oct;62 (Pt 2):393-8.

PMID:
7142977
47.
48.

XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells.

Fischinger PJ, Dunlop NM, Schwarz H, Ihle JN, Weinhold K, Bolognesi DP, Schafer W.

Virology. 1982 May;119(1):68-81. No abstract available.

PMID:
6280386
49.

Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues.

De Rossi A, D'Andrea E, Colombatti A, Fischinger PJ, Chieco-Bianchi L.

J Natl Cancer Inst. 1981 Dec;67(6):1241-50.

PMID:
6273634
50.

Supplemental Content

Loading ...
Support Center